Document Detail

Tranexamic acid mouthwash--a prospective randomized study of a 2-day regimen vs 5-day regimen to prevent postoperative bleeding in anticoagulated patients requiring dental extractions.
MedLine Citation:
PMID:  14759109     Owner:  NLM     Status:  MEDLINE    
This prospective randomized study analyses the use of a prescribed 4.8% tranexamic acid post-operative mouthwash over 2 days vs 5 days to prevent bleeding in patients taking warfarin who require dental extractions. Eighty-five patients therapeutically anticoagulated with warfarin for various conditions, ranging in age from 21 to 86 years and requiring dental extractions, were randomly divided into two groups. Group A postoperatively received a 4.8% tranexamic acid mouthwash to be used over a 2-day period. Group B received the same mouthwash and instructions postoperatively, to be taken over 5 days. All procedures were performed on an ambulatory basis under local anaesthetic by the same surgeon. Patients were reviewed 1, 3, and 7 days postoperatively to assess bleeding. Eighty-two of the 85 patients encountered no postoperative problems. Two patients in group A and one in group B had minor postoperative bleeds that required minor ambulatory intervention to control. This study shows that a 2-day postoperative course of a 4.8% tranexamic acid mouthwash is as equally effective as a 5-day course in controlling haemostasis post-dental extractions in patient's anticoagulated with warfarin.
G Carter; A Goss
Related Documents :
25106789 - Tract-based spatial statistics of diffusion tensor imaging after corpus callosotomy in ...
9536579 - Anticoagulant control in the first three months after mechanical heart valve replacement.
7611119 - Prompt and safe femoral hemostasis with a collagen device after intracoronary implantat...
20598989 - Lowering the intensity of oral anticoagulant therapy in patients with bileaflet mechani...
16784079 - Prevention of thrombosis and embolism in children and adolescents with mechanical valve...
8339409 - Comparison of native prothrombin antigen with the prothrombin time for monitoring oral ...
19190429 - Long-term follow-up after open-window corpectomy in patients with advanced cervical spo...
16199949 - Tibiotalocalcaneal arthrodesis for severe calcaneovalgus deformity in cerebral palsy.
11494619 - Maxillofacial implications and surgical treatment of arthrogryposis multiplex congenita.
Publication Detail:
Type:  Clinical Trial; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  International journal of oral and maxillofacial surgery     Volume:  32     ISSN:  0901-5027     ISO Abbreviation:  Int J Oral Maxillofac Surg     Publication Date:  2003 Oct 
Date Detail:
Created Date:  2004-02-04     Completed Date:  2004-03-10     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  8605826     Medline TA:  Int J Oral Maxillofac Surg     Country:  Denmark    
Other Details:
Languages:  eng     Pagination:  504-7     Citation Subset:  D; IM    
Oral and Maxillofacial Surgery Unit, University of Adelaide, Adelaide, South Australia.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Administration, Topical
Anticoagulants / adverse effects
Antifibrinolytic Agents / administration & dosage*
Dental Care for Chronically Ill*
Middle Aged
Mouthwashes / administration & dosage*
Oral Hemorrhage / etiology,  prevention & control*
Postoperative Hemorrhage / etiology,  prevention & control*
Prospective Studies
Single-Blind Method
Time Factors
Tooth Extraction
Tranexamic Acid / administration & dosage*
Warfarin / adverse effects
Reg. No./Substance:
0/Anticoagulants; 0/Antifibrinolytic Agents; 0/Mouthwashes; 1197-18-8/Tranexamic Acid; 81-81-2/Warfarin

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  A randomized prospective clinical trial on the effectiveness of three treatment modalities for patie...
Next Document:  Prefabrication of vascularized bone flap induced by recombinant human bone morphogenetic protein 2 (...